Cargando…

Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features

OBJECTIVE: Dopamine D2‐like receptors – mainly dopamine D2 receptors (D2R) and dopamine D3 receptors (D3R) – are believed to be greatly involved in the pathology of Parkinson disease (PD) progression. However, these receptors have not been precisely examined in PD patients. Our aim was to quantitati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Pengfei, Knight, William C., Li, Huifangjie, Guo, Yingqiu, Perlmutter, Joel S., Benzinger, Tammie L.S., Morris, John C., Xu, Jinbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818081/ https://www.ncbi.nlm.nih.gov/pubmed/33348472 http://dx.doi.org/10.1002/acn3.51274

Ejemplares similares

The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases
por: Li, Huifangjie, et al.
Publicado: (2019)

Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype
por: Li, Huifangjie, et al.
Publicado: (2020)

Dopamine D(1), D(2), D(3) Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain
por: Sun, Jianjun, et al.
Publicado: (2012)

Radiolabeled 6-(2, 3-Dichlorophenyl)-N4-methylpyrimidine-2, 4-diamine (TH287): A Potential Radiotracer for Measuring and Imaging MTH1
por: Chen, Huaping, et al.
Publicado: (2020)

Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study
por: Han, Fei, et al.
Publicado: (2019)

Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases
por: Li, Huifangjie, et al.
Publicado: (2021)

No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease
por: Tian, LinLin, et al.
Publicado: (2012)

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)

Spatial Reorganization of Putaminal Dopamine D(2)-Like Receptors in Cranial and Hand Dystonia
por: Black, Kevin J., et al.
Publicado: (2014)

Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
por: Bagchi, Devika P., et al.
Publicado: (2013)

The Role of Dopamine and Dopaminergic Pathways in Dystonia: Insights from Neuroimaging
por: Karimi, Morvarid, et al.
Publicado: (2015)

Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
por: Eisenstein, Sarah A., et al.
Publicado: (2015)

Sweet Dopamine: Sucrose Preferences Relate Differentially to Striatal D(2) Receptor Binding and Age in Obesity
por: Pepino, Marta Y., et al.
Publicado: (2016)

Translocator protein in late stage Alzheimer’s disease and Dementia with Lewy bodies brains
por: Xu, Jinbin, et al.
Publicado: (2019)

Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
por: Eisenstein, Sarah A., et al.
Publicado: (2016)

Transient equilibrium determination of dopamine D(2)/D(3) receptor densities and affinities in brain
por: Phan, Jenny-Ann, et al.
Publicado: (2022)

PET Study of Sphingosine-1-phosphate Receptor 1 Expression in Response to S. aureus Infection
por: Jiang, Hao, et al.
Publicado: (2021)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits
por: Carnicella, S, et al.
Publicado: (2014)

Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
por: Bucher, Meghan L., et al.
Publicado: (2020)

Developing Photoaffinity Probes for Dopamine Receptor D(2) to Determine Targets of Parkinson’s Disease Drugs
por: Kim, Spencer T., et al.
Publicado: (2022)

Parkinson disease clinical subtypes: key features & clinical milestones
por: Campbell, Meghan C., et al.
Publicado: (2020)

Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
por: Lanza, Kathryn, et al.
Publicado: (2021)

Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor
por: Bian, Li-hua, et al.
Publicado: (2021)

Dopamine D(1) Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
por: Lewis, Mechelle M., et al.
Publicado: (2023)

Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment
por: Chen, Charles D., et al.
Publicado: (2023)

Impulsive-compulsive behaviour in early Parkinson’s disease is determined by apathy and dopamine receptor D3 polymorphism
por: Theis, Hendrik, et al.
Publicado: (2023)

Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index
por: Eisenstein, Sarah A., et al.
Publicado: (2015)

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease
por: Li, Yanxuan, et al.
Publicado: (2020)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

Specificity of striatal dopamine D(1) system in humans: implications for clinical use of D(1) receptor-agonists in Parkinson's disease
por: Goto, Satoshi
Publicado: (2023)

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
por: Meeker, Karin L., et al.
Publicado: (2022)

Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease
por: Yan, Shaozhen, et al.
Publicado: (2020)

Regulation of Dopamine D1 Receptor Dynamics within the Postsynaptic Density of Hippocampal Glutamate Synapses
por: Ladepeche, Laurent, et al.
Publicado: (2013)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model
por: Tian, LinLin, et al.
Publicado: (2015)

The Spatial Patterns and Determinants of Cerebrospinal Fluid Circulation in the Human Brain
por: Nazeri, Arash, et al.
Publicado: (2023)

Effects of Parkinson’s disease and dopamine on digit span measures of working memory
por: Grogan, John Patrick, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_thikortlkahe3esn0755mc91ho